Exploration of IVIVC Deconvolution Methods in a PBPK Platform: Case Example with Tofacitinib.

Modified-release (MR) drug products are designed to provide controlled drug delivery over time, offering therapeutic and compliance advantages. However, ensuring consistent in vivo performance requires a thorough understanding of the relation between…

Preview only. Read the full abstract at the source